Html code here! Replace this with any non empty raw html code and that's it.

New Alzheimer’s Treatment Could Change Everything

Date:

Share this article:

Del denne artikel:

A new drug candidate developed at UCLA has shown remarkable effects in Alzheimer’s mouse models. Not only did it reduce toxic proteins in the brain, but it also improved memory. Here are the key findings from the breakthrough study.

A Small Molecule With Big Potential

Photo: Shutterstock.com

The experimental drug, DDL-357, is a small molecule that activates the brain’s natural defenses by increasing a beneficial protein.

Targeting Protein Imbalance in the Brain

Photo: Shutterstock.com

Alzheimer’s disease is linked to a buildup of toxic proteins that disrupt cell communication. This treatment helps restore balance.

Clusterin: The Brain’s Natural Shield

DDL-357 boosts the production of secreted clusterin, a protein known to protect brain cells from damage and degeneration.

Also read: Breakthrough Study: Can We Finally Detox Microplastics from Our Blood?

More Clusterin, Less Damage

Photo: Shutterstock.com

Researchers observed a drop in levels of phospho-tau — a toxic protein tied to disease progression — after treatment with DDL-357.

Boosting Mitochondrial Function

Photo: Shutterstock.com

The drug also improved the energy-producing structures in brain cells, suggesting better overall cellular health.

Measurable Memory Improvement

Photo: Shutterstock.com

Mice treated with DDL-357 performed significantly better in memory and maze tests, showing real cognitive benefits.

A Shift in Alzheimer’s Treatment Strategy

Photo: Shutterstock.com

Unlike traditional approaches that only slow the disease, this drug shows potential for actually restoring lost brain function.

Also read: Easy Ways to Stay Fit on Vacation – Without Ruining the Fun!

Potential Beyond Alzheimer’s

Photo: Shutterstock.com

Researchers believe the drug could also be effective in treating other brain disorders like Parkinson’s and ALS.

One of Several Promising Compounds

Photo: Shutterstock.com

DDL-357 is part of a wider pipeline of candidate drugs developed at UCLA, including compounds that target brain circuits and other protective proteins.

Human Trials Still Years Away

Though results are exciting, the drug remains in early testing. Extensive research is needed before it can be tested in people.

Article Based on Information from News Medical

Also read: New Treatment Offers Hope for Children and Adults With Aggressive Leukemia

Also read: How Much Sunscreen You Should Use on Your Face – According to Experts

Other articles

Breakthrough Study: Can We Finally Detox Microplastics from Our Blood?

Microplastics have been found in the human body — but can they be removed? A new study explores...

10 Healthy Foods that Won’t Break Your Budget

Healthy eating doesn’t have to drain your wallet. Here are some affordable and nutrient-packed foods that are easy...

Easy Ways to Stay Fit on Vacation – Without Ruining the Fun!

Vacations are meant for relaxation, indulgence, and freedom from routines - but that doesn’t mean your healthy habits...

New Treatment Offers Hope for Children and Adults With Aggressive Leukemia

Researchers at the University of Cambridge have developed a potential new therapy for B-cell acute lymphoblastic leukemia (B-ALL),...

Breakthrough Study: Can We Finally Detox Microplastics from Our Blood?

Microplastics have been found in the human body — but can they be removed? A new study explores...

10 Healthy Foods that Won’t Break Your Budget

Healthy eating doesn’t have to drain your wallet. Here are some affordable and nutrient-packed foods that are easy...

Easy Ways to Stay Fit on Vacation – Without Ruining the Fun!

Vacations are meant for relaxation, indulgence, and freedom from routines - but that doesn’t mean your healthy habits...